-
1دورية أكاديمية
المؤلفون: Iheke, James, Theodosakis, Nicholas, Ugwu-Dike, Pearl, Seo, Jayhyun, Tang, Kimberly, Sise, Meghan E, Semenov, Yevgeniy R, Tiu, Bruce, Mooradian, Meghan, Sullivan, Ryan, Zubiri, Leyre, Naidoo, Jarushka, Pahalyants, Vartan, Reynolds, Kerry Lynn
المصدر: Journal for immunotherapy of cancer ; 10 ; 6 ; England
مصطلحات موضوعية: IMMUNOTHERAPY, lung neoplasms, programmed cell death 1 receptor
العلاقة: http://hdl.handle.net/10147/635053Test; Journal for immunotherapy of cancer; PMC9204442
-
2دورية أكاديمية
المؤلفون: Anagnostou, Valsamo, Smith, Kellie N, Forde, Patrick M, Niknafs, Noushin, Bhattacharya, Rohit, White, James, Zhang, Theresa, Adleff, Vilmos, Phallen, Jillian, Wali, Neha, Hruban, Carolyn, Guthrie, Violeta B, Rodgers, Kristen, Naidoo, Jarushka, Kang, Hyunseok, Sharfman, William, Georgiades, Christos, Verde, Franco, Illei, Peter, Li, Qing Kay, Gabrielson, Edward, Brock, Malcolm V, Zahnow, Cynthia A, Baylin, Stephen B, Scharpf, Robert B, Brahmer, Julie R, Karchin, Rachel, Pardoll, Drew M, Velculescu, Victor E
المصدر: Cancer Discovery. 7(3)
مصطلحات موضوعية: Prevention, Cancer, Immunization, Clinical Research, Lung, Lung Cancer, 5.1 Pharmaceuticals, Development of treatments and therapeutic interventions, Aetiology, 2.1 Biological and endogenous factors, Good Health and Well Being, Adult, Antibodies, Monoclonal, Antigens, Neoplasm, Antineoplastic Agents, Immunological, CTLA-4 Antigen, Carcinoma, Non-Small-Cell Lung, Cell Cycle Checkpoints, Cohort Studies, Drug Resistance, Neoplasm, Female, Humans, Immunotherapy, Ipilimumab, Janus Kinase 1, Janus Kinase 2, Lung Neoplasms, Male, Middle Aged, Mutation, Nivolumab, Programmed Cell Death 1 Receptor, Receptors, Antigen, T-Cell, Oncology and Carcinogenesis
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/7hc6g632Test
-
3دورية أكاديمية
المؤلفون: McMahon, David John, McLaughlin, Ronan, Naidoo, Jarushka
المصدر: Cancers; Feb2024, Vol. 16 Issue 3, p527, 26p
مصطلحات موضوعية: LUNG cancer, DRUG efficacy, DISEASE progression, GENETIC mutation, ONCOGENES, TREATMENT effectiveness, PATIENT care, IMMUNOTHERAPY, PATIENT safety, DRUG toxicity
-
4دورية أكاديمية
المؤلفون: Al-Rajabi, Taiseer, Naidoo, Jarushka, Jun Zhang
المصدر: Frontiers in Oncology; 2023, p1-4, 4p
مصطلحات موضوعية: LUNG cancer, IMMUNOTHERAPY, IMMUNE checkpoint inhibitors, NON-small-cell lung carcinoma
-
5دورية أكاديمية
المؤلفون: Stanley, Robyn, Flanagan, Saoirse, Reilly, David O', Kearney, Ella, Naidoo, Jarushka, Dowling, Catríona M.
المصدر: Cancers; Jun2023, Vol. 15 Issue 11, p2996, 23p
مصطلحات موضوعية: LUNG cancer, SURVIVAL, IMMUNE checkpoint inhibitors, QUALITY of life, IMMUNOTHERAPY, MEDICAL research, DRUG toxicity, COMORBIDITY, DISEASE risk factors
-
6دورية أكاديمية
المؤلفون: Fan, Christopher, Kim, Ahyoung, Li, Sean, Naidoo, Jarushka, Cappelli, Laura C., Brahmer, Julie R., Anders, Robert A., Kim, Amy K.
المصدر: Journal of Cancer Research & Clinical Oncology; Feb2023, Vol. 149 Issue 2, p877-883, 7p
مصطلحات موضوعية: HEPATOTOXICOLOGY, IMMUNE checkpoint inhibitors, LIVER enzymes, LIVER failure, BILE ducts, ANTI-NMDA receptor encephalitis
-
7
المؤلفون: Conroy, Michael, Naidoo, Jarushka
المصدر: Nature Communications
Nature Communications, Vol 13, Iss 1, Pp 1-4 (2022)مصطلحات موضوعية: Clinical Trials as Topic, Multidisciplinary, Adverse effects, Science, animal diseases, Comment, General Physics and Astronomy, chemical and pharmacologic phenomena, Cancer immunotherapy, General Chemistry, biochemical phenomena, metabolism, and nutrition, General Biochemistry, Genetics and Molecular Biology, Prognostic markers, Disease Models, Animal, Neoplasms, bacteria, Tumour immunology, Animals, Humans, Immunotherapy, Immune Checkpoint Inhibitors
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a939ab57a622ba627c973f19213252b9Test
https://doi.org/10.1038/s41467-022-27960-2Test -
8دورية أكاديمية
المؤلفون: Thuny, Franck, Naidoo, Jarushka, Neilan, Tomas G
المصدر: European Heart Journal; 11/7/2022, Vol. 43 Issue 42, p4458-4468, 11p
مصطلحات موضوعية: IMMUNE checkpoint inhibitors, IMMUNOTHERAPY, CARDIOLOGICAL manifestations of general diseases, IPILIMUMAB, CANCER chemotherapy, CANCER treatment, CARDIOVASCULAR system
-
9دورية أكاديمية
المؤلفون: Hsu, Melinda L, Murray, Joseph C, Psoter, Kevin J, Zhang, Jiajia, Barasa, Durrant, Brahmer, Julie R, Ettinger, David S, Forde, Patrick M, Hann, Christine L, Lam, Vincent K, Levy, Benjamin, Marrone, Kristen A, Patel, Tricia, Peterson, Valerie, Sagorsky, Sarah, Turner, Michelle, Anagnostou, Valsamo, Naidoo, Jarushka, Feliciano, Josephine L
المصدر: Oncologist; Nov2022, Vol. 27 Issue 11, p971-981, 11p, 1 Diagram, 3 Charts, 2 Graphs
مصطلحات موضوعية: DRUG side effects, LUNG cancer, IMMUNE checkpoint inhibitors, LUNG tumors, RETROSPECTIVE studies, REGRESSION analysis, TREATMENT duration, CANCER patients, TREATMENT effectiveness, RISK assessment, DESCRIPTIVE statistics, DEMOGRAPHY, LOGISTIC regression analysis, ODDS ratio, DRUG toxicity, IMMUNOTHERAPY, SYMPTOMS
-
10دورية أكاديمية
المؤلفون: Scott, Susan C., Shao, Xiaoshan M., Niknafs, Noushin, Balan, Archana, Pereira, Gavin, Marrone, Kristen A., Lam, Vincent K., Murray, Joseph C., Feliciano, Josephine L., Levy, Benjamin P., Ettinger, David S., Hann, Christine L., Brahmer, Julie R., Forde, Patrick M., Karchin, Rachel, Naidoo, Jarushka, Anagnostou, Valsamo
المصدر: Frontiers in Oncology; 8/3/2022, Vol. 12, p1-12, 12p
مصطلحات موضوعية: IMMUNE checkpoint proteins, NON-small-cell lung carcinoma, SEXUAL dimorphism, IMMUNE response, IMMUNE checkpoint inhibitors